1. Home
  2. CASS vs FBRX Comparison

CASS vs FBRX Comparison

Compare CASS & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cass Information Systems Inc

CASS

Cass Information Systems Inc

N/A

Current Price

$46.41

Market Cap

596.8M

ML Signal

N/A

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

N/A

Current Price

$21.94

Market Cap

487.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CASS
FBRX
Founded
1906
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
596.8M
487.2M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
CASS
FBRX
Price
$46.41
$21.94
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$45.00
$67.00
AVG Volume (30 Days)
54.5K
191.2K
Earning Date
04-23-2026
05-14-2026
Dividend Yield
2.75%
N/A
EPS Growth
87.77
61.30
EPS
0.67
N/A
Revenue
$190,750,000.00
$36,000.00
Revenue This Year
$0.81
N/A
Revenue Next Year
$4.39
N/A
P/E Ratio
$69.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.07
$7.78
52 Week High
$52.45
$35.80

Technical Indicators

Market Signals
Indicator
CASS
FBRX
Relative Strength Index (RSI) 52.59 39.84
Support Level $45.20 $18.18
Resistance Level $47.93 $22.61
Average True Range (ATR) 1.11 1.95
MACD -0.04 -0.16
Stochastic Oscillator 53.26 36.36

Price Performance

Historical Comparison
CASS
FBRX

About CASS Cass Information Systems Inc

Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution, and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. Additionally, the firm has a banking subsidiary, offering banking services mainly to privately held businesses in the St. Louis metropolitan area and restaurant franchises and faith-based ministries within the United States. The company operates in two reportable segments: Information Services, which generates the maximum revenue, and Banking Services.

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Share on Social Networks: